
Teleflex (TFX) Stock Forecast & Price Target
Teleflex (TFX) Analyst Ratings
Bulls say
Teleflex Inc. is positioned favorably for strong financial performance, driven by anticipated revenue growth exceeding mid-single digits and improved operating margins that may lead to double-digit earnings growth. The company’s strategic business mix, particularly in the Interventional cardiology sector, is expected to capitalize on market share gains following a competitor's exit, further enhancing its growth potential. Additionally, the possibility of repaying debt and share repurchases could bolster earnings per share in the upcoming years, reinforcing a positive outlook for the company's financial trajectory.
Bears say
Teleflex Inc. has experienced a deterioration in its organic revenue and earnings per share (EPS) growth, lagging behind industry peers, which raises concerns about its future performance. Recent financial reports indicate that the company’s organic growth was only 2.1%, falling short of the expected 2.7%, and specific segments, such as Interventional and Interventional Urology, reported significant weaknesses. Additionally, management has flagged risks associated with slower-than-anticipated growth from key drivers and potential dilutive effects from larger acquisitions, further contributing to a negative outlook on the company's stock.
This aggregate rating is based on analysts' research of Teleflex and is not a guaranteed prediction by Public.com or investment advice.
Teleflex (TFX) Analyst Forecast & Price Prediction
Start investing in Teleflex (TFX)
Order type
Buy in
Order amount
Est. shares
0 shares